MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

28 Oct 2021 Evaluate
The turnover soared 50.89% to Rs. 335.12 millions for the September 2021 quarter as compared to Rs. 222.09 millions during the corresponding quarter last year.The Company's Net profit for the September 2021 quarter have declined marginally to Rs. 40.36  millions as against Rs. 42.63 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 54.94 millions from 57.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 335.12 222.09 50.89 626.92 433.62 44.58 868.71 456.33 90.37
Other Income 2.32 5.19 -55.30 12.24 19.87 -38.40 18.10 5.95 204.20
PBIDT 54.94 57.20 -3.95 114.57 120.17 -4.66 206.98 92.73 123.21
Interest 0.14 0.00 0.00 0.17 0.00 0.00 0.13 0.00 0.00
PBDT 54.80 57.20 -4.20 114.40 120.17 -4.80 206.85 92.73 123.07
Depreciation 0.67 0.30 123.33 0.93 0.37 151.35 0.88 0.08 1000.00
PBT 54.13 56.90 -4.87 113.47 119.80 -5.28 205.97 92.65 122.31
TAX 13.77 14.27 -3.50 28.78 30.10 -4.39 54.64 27.70 97.26
Deferred Tax 0.22 -0.01 -2300.00 0.21 0.04 425.00 0.04 0.04 0.00
PAT 40.36 42.63 -5.32 84.69 89.70 -5.59 151.33 64.95 132.99
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 16.39 25.76 -36.35 18.28 27.71 -34.06 23.83 20.32 17.25
Peers